Prostate cancer screening

Prostate cancer screening

Ankerst, D.P.
Tangen, C.M.
Thompson, I.M.

155,95 €(IVA inc.)

More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screeningand biomarkers for the disease. In Prostate Cancer Screening, Second Edition,the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, tocutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians. Comprehensively reviews every aspect of prostate cancer screening, including the latest discoveries in biomarker research Outlines current screening policies by continent and presents the relative ongoing prospective screening trials around the globe INDICE: From the contents I. Trends in prostate cancer screening. II. Prostate Specific Antigen. III. Risk assessment for prostate cancer. IV. Recent biomarkers for prostate cancer. V. Design and methodologic considerations in biomarker studies. VI. Building upon recently completed and ongoing prospective trials.

  • ISBN: 978-1-60327-280-3
  • Editorial: Humana
  • Encuadernacion: Cartoné
  • Páginas: 555
  • Fecha Publicación: 01/02/2009
  • Nº Volúmenes: 1
  • Idioma: Inglés